New Prescriber Registration Form


Professional Disclosure: Dr. Fram is on the Medical Advisory Board for Ocular Science® (an affiliate of OSRX) and has a financial interest in the company.

OSRX operates in compliance with Section 503A regarding compounded drugs as defined in the FD&C Act.

*Compounded drugs are not FDA-approved, which means they have not undergone FDA premarket review for safety, effectiveness, and quality. 503A compounding pharmacies are not required to comply with cGMP requirements but can be inspected by FDA. References available upon request.

Click here to view potential contraindications.